期刊
CHEMMEDCHEM
卷 16, 期 12, 页码 1917-1926出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202100029
关键词
beta-carboline; kappa opioid receptor agonist; molecular modeling; nitrogen heterocycle; pain
资金
- Council of Scientific and Industrial Research, New Delhi
- University Grants Commission, New Delhi
- Indian Council of Medical Research, New Delhi
- Department of Biotechnology, New Delhi
- Ministry of Earth Sciences, New Delhi [MoES/09-DS/07/2014 PC-IV]
The synthesis of new fused beta-carboline derivatives led to the discovery of two compounds with significant agonistic activity on KOR, which were found to be extremely G-protein-biased agonists. These compounds demonstrated analgesic effects in mice, without inducing sedation, and their interaction with the human KOR was studied for rationalization of the results.
The synthesis of 5-formyl-6-aryl-6H-indolo[3,2,1-de][1,5] naphthyridine-2-carboxylates by reaction between 1-formyl-9H-beta-carbolines and cinnamaldehydes in the presence of pyrrolidine in water with microwave irradiation is described. Pharmacophoric modification of the formyl group offered several new fused beta-carboline derivatives, which were investigated for their kappa-opioid receptor (KOR) agonistic activity. Two compounds 4 a and 4 c produced appreciable agonist activity on KOR with EC50 values of 46 +/- 19 and 134 +/- 9 nM, respectively. Moreover, compound-induced KOR signaling studies suggested both compounds to be extremely G-protein-biased agonists. The analgesic effect of 4 a was validated by the increase in tail flick latency in mice in a time-dependent manner, which was completely blocked by the KOR-selective antagonist norBNI. Moreover, unlike U50488, an unbiased full KOR agonist, 4 a did not induce sedation. The docking of 4 a with the human KOR was studied to rationalize the result.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据